Epidural Current-Steering for Selective Modulation of Lower Urinary Tract Function
硬膜外电流引导选择性调节下尿路功能
基本信息
- 批准号:10008078
- 负责人:
- 金额:$ 74.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:Action PotentialsAdverse eventAfferent PathwaysAgingAnatomyAxonBiological AssayBiological ModelsBladderBladder ControlChronicClinicalCommunicationCritical PathwaysDataData Coordinating CenterDevelopmentDevice or Instrument DevelopmentDevicesDiseaseDura MaterElectrodesElectromyographyElectronicsElectrophysiology (science)EncapsulatedFunctional disorderFutureGeometryHumanImpairmentImplantImplanted ElectrodesIncontinenceInjuryLasersLeadLower urinary tractMapsMeasuresMethodsModelingMoldsMonitorMotorMuscleNerveNeurostimulation procedures of spinal cord tissueOrganOrgan ModelOutputOveractive BladderParasympathetic Nervous SystemPathway interactionsPelvisPerformancePeripheral NervesPhasePhysiologic pulsePhysiologicalPhysiologyPositioning AttributeProcessQuality of lifeResearchResolutionSacral spinal cord structureSiliconSiliconesSphincterSpinal CordSpinal nerve root structureStretchingStructureSurfaceSymptomsSystemTechniquesTechnologyThickThinnessTimeTranslatingUniversitiesUrethraWaterafferent nervebasebody systemclinically relevantcostdensityelectric fieldexperienceexperimental studyflexibilityfunctional improvementimplantationimprovedin vivointravesicalmultidisciplinarynanofiberneural circuitneuroregulationnovelpressurepreventrecruitrelating to nervous systemresponsespinal cord mappingtechnology developmenttool
项目摘要
DESCRIPTION. A high-density Stim-Grid MAP spinal cord stimulation lead technology is proposed to enable
the creation of predictive maps that detail how lower urinary tract nerve pathways can be activated through high-
density stimulation of the sacral spinal cord and roots. These maps will enable principled development of
neuromodulation therapies that use spinal cord stimulation to alleviate the burden of overactive bladder and
incontinence. The lower urinary tract (LUT), consisting of the bladder, urethra and associated muscles and nerves,
is an important target organ system for neuromodulation therapies as injury, disease and aging can lead to
impairment and subsequent reductions in the quality of life. While existing neuromodulation devices have been
implanted in over 200,000 people, device related adverse events remain common, and despite functional
improvements, many people still deal with unwanted symptoms of overactive bladder and incontinence. Using
electric field modelling, our multidisciplinary team has demonstrated that a two-fold increase in electrode
columns and density can deliver stimulation to laterally-positioned spinal cord targets not possible with existing
clinical electrodes. Furthermore, we have demonstrated feasibility of manufacturing ultra-flexible electrodes that
can conform to the plexus geometry of the sacral spinal cord. The objective of this technology development effort
is to develop and commercialize a 64-channel active-lead which contains 8-columns and 8 rows, and to develop
maps of the accessibility of LUT peripheral nerves through spinal cord stimulation. We seek to perform three
development tasks: (AIM 1) Develop a contoured and passive high-density epidural spinal-cord paddle array,
(AIM 2): Develop a STIM-GRID MAP spinal cord paddle with a switch-matrix electronics package, (AIM 3)
Develop maps of LUT recruitment by high-resolution stimulation of the sacral spinal cord. Our multi-disciplinary
team includes device development (Micro-Leads) and bladder electrophysiology (University of Pittsburgh). In
Year 1 we will create and demonstrate a 48-channel flexible and high-density passive lead and create maps that
describe the selective access to the pelvic nerve, pudendal nerve and pudendal nerve branches. In Year 2 we will
demonstrate a Stim-Grid MAP array with 8 columns and 8-rows (64-channels of resolution) using only 16 wires.
The high-resolution array will enable us to generate maps of LUT peripheral nerve access at the spinal cord, but
importantly, is immediately scalable to map other organ models with little additional development effort and time.
Because the Stim-Grid MAP technology is based on well-understood implantable spinal cord lead implantation
techniques, this technology could be rapidly translated to high-resolution spinal cord mapping experiments in
people during an intraoperative settings in an OT3 phase.
说明.提出了一种高密度Stim-Grid MAP脊髓刺激电极导线技术,
建立预测地图,详细说明下尿路神经通路如何通过高-
密度刺激骶髓和神经根。这些地图将使有原则的发展,
神经调节疗法,其使用脊髓刺激来减轻膀胱过度活动症的负担,
失禁下尿路(LUT),包括膀胱、尿道和相关的肌肉和神经,
是神经调节治疗的重要靶器官系统,因为损伤、疾病和衰老可导致
损害和随后的生活质量下降。虽然现有的神经调节装置已经被
在超过200,000人中植入,与器械相关的不良事件仍然很常见,
尽管有了很大的改善,许多人仍然需要处理膀胱过度活动症和尿失禁的不必要的症状。使用
电场建模,我们的多学科团队已经证明,电极的两倍增加,
柱和密度可以将刺激传递到横向定位的脊髓目标,
临床电极此外,我们已经证明了制造超柔性电极的可行性,
可以符合骶骨脊髓的神经丛几何形状。这项技术开发工作的目标是
是开发和商业化包含8列和8行的64通道有源引线,
通过脊髓刺激的LUT周围神经的可达性的地图。我们力求做到三个
开发任务:(目标1)开发一种轮廓和被动高密度硬膜外脊髓桨阵列,
(AIM 2):开发带有开关矩阵电子组件的STIM-GRID MAP脊髓桨(AIM 3)
通过骶髓高分辨率刺激绘制LUT募集图。我们的多学科
团队包括设备开发(Micro-Leads)和膀胱电生理学(匹兹堡大学)。在
第1年,我们将创建并演示48通道灵活的高密度无源电极导线,并创建
描述盆腔神经、阴部神经和阴部神经分支的选择性通路。在第二年,我们将
演示仅使用16根导线的8列8行(64通道分辨率)刺激网格MAP阵列。
高分辨率的阵列将使我们能够生成LUT周围神经进入脊髓的地图,
重要的是,它可以立即扩展到映射其他器官模型,而只需很少的额外开发工作和时间。
由于刺激网格MAP技术基于众所周知的植入式脊髓电极导线植入
技术,这项技术可以迅速转化为高分辨率的脊髓映射实验,
在OT 3阶段的术中设置期间的人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bryan L McLaughlin其他文献
High-density spinal cord stimulation selectively activates lower urinary tract afferents
高密度脊髓刺激选择性激活下尿路传入神经
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Maria K. Jantz;Chaitanya Gopinath;Ritesh Kumar;C. Chin;Liane Wong;John I. Ogren;L. Fisher;Bryan L McLaughlin;R. Gaunt - 通讯作者:
R. Gaunt
Bryan L McLaughlin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bryan L McLaughlin', 18)}}的其他基金
The Commercialization of High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛的商业化
- 批准号:
10822401 - 财政年份:2023
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
10488074 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
10778743 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
10406102 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
9898661 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
10224988 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
高分辨率脊髓刺激用于非阿片类药物治疗神经性疼痛
- 批准号:
10249370 - 财政年份:2019
- 资助金额:
$ 74.15万 - 项目类别:
Epidural Current-Steering for Selective Modulation of Lower Urinary Tract Function
硬膜外电流引导选择性调节下尿路功能
- 批准号:
9415526 - 财政年份:2017
- 资助金额:
$ 74.15万 - 项目类别:
Epidural Current-Steering for Selective Modulation of Lower Urinary Tract Function
硬膜外电流引导选择性调节下尿路功能
- 批准号:
10202325 - 财政年份:2017
- 资助金额:
$ 74.15万 - 项目类别:
相似海外基金
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10707830 - 财政年份:2023
- 资助金额:
$ 74.15万 - 项目类别:
Hospital characteristics and Adverse event Rate Measurements (HARM) Evaluated over 21 years.
医院特征和不良事件发生率测量 (HARM) 经过 21 年的评估。
- 批准号:
479728 - 财政年份:2023
- 资助金额:
$ 74.15万 - 项目类别:
Operating Grants
Analysis of ECOG-ACRIN adverse event data to optimize strategies for the longitudinal assessment of tolerability in the context of evolving cancer treatment paradigms (EVOLV)
分析 ECOG-ACRIN 不良事件数据,以优化在不断发展的癌症治疗范式 (EVOLV) 背景下纵向耐受性评估的策略
- 批准号:
10884567 - 财政年份:2023
- 资助金额:
$ 74.15万 - 项目类别:
AE2Vec: Medical concept embedding and time-series analysis for automated adverse event detection
AE2Vec:用于自动不良事件检测的医学概念嵌入和时间序列分析
- 批准号:
10751964 - 财政年份:2023
- 资助金额:
$ 74.15万 - 项目类别:
Understanding the real-world adverse event risks of novel biosimilar drugs
了解新型生物仿制药的现实不良事件风险
- 批准号:
486321 - 财政年份:2022
- 资助金额:
$ 74.15万 - 项目类别:
Studentship Programs
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10676786 - 财政年份:2022
- 资助金额:
$ 74.15万 - 项目类别:
Pediatric Adverse Event Risk Reduction for High Risk Medications in Children and Adolescents: Improving Pediatric Patient Safety in Dental Practices
降低儿童和青少年高风险药物的儿科不良事件风险:提高牙科诊所中儿科患者的安全
- 批准号:
10440970 - 财政年份:2022
- 资助金额:
$ 74.15万 - 项目类别:
Improving Adverse Event Reporting on Cooperative Oncology Group Trials
改进肿瘤学合作组试验的不良事件报告
- 批准号:
10642998 - 财政年份:2022
- 资助金额:
$ 74.15万 - 项目类别:
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event risk
胃肠道干细胞平面培养用于筛选药物不良事件风险
- 批准号:
10482465 - 财政年份:2022
- 资助金额:
$ 74.15万 - 项目类别:
Expanding and Scaling Two-way Texting to Reduce Unnecessary Follow-Up and Improve Adverse Event Identification Among Voluntary Medical Male Circumcision Clients in the Republic of South Africa
扩大和扩大双向短信,以减少南非共和国自愿医疗男性包皮环切术客户中不必要的后续行动并改善不良事件识别
- 批准号:
10191053 - 财政年份:2020
- 资助金额:
$ 74.15万 - 项目类别: